These results suggested that hPD-L1 expression can indicate the activation status of the immune tolerance mechanism that occurs in certain immune cell fractions such as CD16+ Mo, Mo/Mφ, MDSC, mDC, and DC in response to increased immune cell infiltration, mainly effector cells that secrete interferon-gamma to induce PD-L1 expression on various cells, into the breast cancer microenvironment. The gene discussed is IFNG; the disease is breast cancer.